Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

MedWellAI (MWAI) EPS (Weighted Average and Diluted) (2016 - 2025)

MedWellAI (MWAI) has disclosed EPS (Weighted Average and Diluted) for 10 consecutive years, with -$0.05 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 25.0% to -$0.05 in Q4 2025 year-over-year; TTM through Dec 2025 was -$0.46, a 276.92% decrease, with the full-year FY2025 number at -$0.49, up 77.52% from a year prior.
  • EPS (Weighted Average and Diluted) was -$0.05 for Q4 2025 at MedWellAI, up from -$0.09 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.42 in Q2 2024 to a low of -$9.78 in Q2 2023.
  • A 5-year average of -$0.84 and a median of -$0.1 in 2025 define the central range for EPS (Weighted Average and Diluted).
  • Peak YoY movement for EPS (Weighted Average and Diluted): surged 222.67% in 2021, then tumbled 58971.12% in 2022.
  • MedWellAI's EPS (Weighted Average and Diluted) stood at -$0.0 in 2021, then crashed by 58971.12% to -$1.32 in 2022, then crashed by 96.97% to -$2.6 in 2023, then surged by 98.46% to -$0.04 in 2024, then dropped by 25.0% to -$0.05 in 2025.
  • Per Business Quant, the three most recent readings for MWAI's EPS (Weighted Average and Diluted) are -$0.05 (Q4 2025), -$0.09 (Q3 2025), and -$0.22 (Q2 2025).